in Reason 2 O O
infants Reason 2 O O
vaccinated Reason 2 O O
with Reason 2 O O
the Reason 2 O O
human Reason 2 O O
rotavirus Reason 2 O O
vaccine, Reason 2 O O
Rotarix: Reason 2 O O
A Reason 2 O O
retrospective Reason 2 O O
laboratory Reason 2 O O
analysis Reason 2 O O
circovirus Reason 2 O O
1 Reason 2 O O
(PCV1) Reason 2 O O
in Reason 2 O O
infants Reason 2 O O
vaccinated Reason 2 O O
with Reason 2 O O
the Reason 2 O O
human Reason 2 O O
rotavirus Reason 2 O O
vaccine, Reason 2 O O
Rotarix: Reason 2 O O
A Reason 2 O O
retrospective Reason 2 O O
laboratory Reason 2 O O
analysis Reason 2 O O
Abstract Reason 2 O O
In Reason 2 O O
2010, Reason 2 O O
porcine Reason 2 O O
circovirus Reason 2 O O
type Reason 2 O O
1 Reason 2 O O
(PCV1) Reason 2 O O
material Reason 2 O O
was Reason 2 O O
unexpectedly Reason 2 O O
detected Reason 2 O O
in Reason 2 O O
the Reason 2 O O
oral Reason 2 O O
live-attenuated Reason 2 O O
human Reason 2 O O
rotavirus Reason 2 O O
(RV) Reason 2 O O
vaccine, Reason 2 O O
Rotarix Reason 2 O O
(GSK Reason 2 O O
Vaccines, Reason 2 O O
Belgium). Reason 2 O O
An Reason 2 O O
initial Reason 2 O O
study Reason 2 O O
([NCT01511133](http://clinicaltrials.gov/show/NCT01511133)) Reason 2 O O
found Reason 2 O O
no Reason 2 O O
immunologic Reason 2 O O
response Reason 2 O O
against Reason 2 O O
PCV1 Reason 2 O O
in Reason 2 O O
40 Reason 2 O O
vaccinated Reason 2 O O
infants. Reason 2 O O
As Reason 2 O O
a Reason 2 O O
follow-up, Reason 2 O O
the Reason 2 O O
current Reason 2 O O
study Reason 2 O O
([NCT02153333](http://clinicaltrials.gov/show/NCT02153333)), Reason 2 O O
searched Reason 2 O O
for Reason 2 O O
evidence Reason 2 O O
of Reason 2 O O
post-vaccination Reason 2 O O
serologic Reason 2 O O
response Reason 2 O O
to Reason 2 O O
PCV1 Reason 2 O O
in Reason 2 O O
a Reason 2 O O
larger Reason 2 O O
number Reason 2 O O
of Reason 2 O O
archived Reason 2 O O
serum Reason 2 O O
samples. Reason 2 O O
Unlike Reason 2 O O
the Reason 2 O O
previous Reason 2 O O
study, Reason 2 O O
serum Reason 2 O O
anti-PCV1 Reason 2 O O
antibodies Reason 2 O O
assessed Reason 2 O O
with Reason 2 O O
an Reason 2 O O
(IPMA) Reason 2 O O
using Reason 2 O O
a Reason 2 O O
Vero-adapted Reason 2 O O
PCV1 Reason 2 O O
strain. Reason 2 O O
Samples Reason 2 O O
from Reason 2 O O
596 Reason 2 O O
infants Reason 2 O O
who Reason 2 O O
participated Reason 2 O O
in Reason 2 O O
clinical Reason 2 O O
trials Reason 2 O O
of Reason 2 O O
the Reason 2 O O
human Reason 2 O O
RV Reason 2 O O
vaccine Reason 2 O O
were Reason 2 O O
randomly Reason 2 O O
selected Reason 2 O O
and Reason 2 O O
analyzed. Reason 2 O O
The Reason 2 O O
observed Reason 2 O O
anti-PCV1 Reason 2 O O
antibody Reason 2 O O
seropositivity Reason 2 O O
rate Reason 2 O O
1-2 Reason 2 O O
months Reason 2 O O
post-dose Reason 2 O O
[90% Reason 2 O O
Confidence Reason 2 O O
Interval Reason 2 O O
(CI): Reason 2 O O
0.3-2.6] Reason 2 O O
(3/299 Reason 2 O O
samples) Reason 2 O O
in Reason 2 O O
infants Reason 2 O O
who Reason 2 O O
received Reason 2 O O
the Reason 2 O O
human Reason 2 O O
RV Reason 2 O O
vaccine Reason 2 O O
and Reason 2 O O
0.3% Reason 2 O O
[90% Reason 2 O O
CI: Reason 2 O O
0.0-1.6] Reason 2 O O
(1/297 Reason 2 O O
samples) Reason 2 O O
in Reason 2 O O
those Reason 2 O O
who Reason 2 O O
received Reason 2 O O
difference Reason 2 O O
between Reason 2 O O
the Reason 2 O O
groups Reason 2 O O
was Reason 2 O O
-0.66 Reason 2 O O
[90% Reason 2 O O
CI: Reason 2 O O
-2.16-0.60]. Reason 2 O O
One Reason 2 O O
subject Reason 2 O O
in Reason 2 O O
the Reason 2 O O
vaccinated Reason 2 O O
group Reason 2 O O
was Reason 2 O O
also Reason 2 O O
seropositive Reason 2 O O
before Reason 2 O O
vaccination. Reason 2 O O
Notably, Reason 2 O O
the Reason 2 O O
seropositivity Reason 2 O O
rate Reason 2 O O
observed Reason 2 O O
in Reason 2 O O
vaccinated Reason 2 O O
subjects Reason 2 O O
was Reason 2 O O
below Reason 2 O O
that Reason 2 O O
observed Reason 2 O O
during Reason 2 O O
assay Reason 2 O O
qualification Reason 2 O O
in Reason 2 O O
samples Reason 2 O O
from Reason 2 O O
unvaccinated Reason 2 O O
subjects Reason 2 O O
outside Reason 2 O O
of Reason 2 O O
this Reason 2 O O
study Reason 2 O O
(2.5%; Reason 2 O O
5/200 Reason 2 O O
samples). Reason 2 O O
No O O O O
serious O O O O
adverse O O O O
events O O O O
had O O O O
been O O O O
reported O O O O
in O O O O
any O O O O
of O O O O
the O O O O
4 O O O O
subjects O O O O
providing O O O O
anti-PCV1 O O O O
positive O O O O
samples O O O O
during O O O O
the O O O O
31-day O O O O
post-vaccination O O O O
follow-up O O O O
period O O O O
in O O O O
the O O O O
original O O O O
studies. O O O O
In O O O O
conclusion, O O O O
the O O O O
presence O O O O
of O O O O
PCV1 O O O O
in O O O O
the O O O O
human O O O O
RV O O O O
vaccine O O O O
is O O O O
considered O O O O
to O O O O
be O O O O
a O O O O
manufacturing O O O O
quality O O O O
issue O O O O
and O O O O
does O O O O
not O O O O
appear O O O O
to O O O O
pose O O O O
a O O O O
safety O O O O
risk O O O O
to O O O O
vaccinated O O O O
infants. O O O O
Keywords: O O O O
Similar O O O O
articles O O O O
- O O O O
[Investigation O O O O
of O O O O
a O O O O
regulatory O O O O
agency O O O O
enquiry O O O O
into O O O O
potential O O O O
porcine O O O O
circovirus O O O O
type O O O O
1 O O O O
contamination O O O O
of O O O O
the O O O O
human O O O O
rotavirus O O O O
PMC O O O O
article. O O O O
- O O O O
[A O O O O
safety O O O O
and O O O O
immunogenicity O O O O
study O O O O
of O O O O
a O O O O
new O O O O
live O O O O
attenuated O O O O
human O O O O
rotavirus O O O O
vaccine O O O O
human O O O O
rotavirus O O O O
vaccine O O O O
Rotarix O O O O
in O O O O
infants: O O O O
an O O O O
Free O O O O
PMC O O O O
article. O O O O
Clinical O O O O
Trial. O O O O
[Immunogenicity O O O O
and O O O O
reactogenicity O O O O
of O O O O
the O O O O
human O O O O
rotavirus O O O O
vaccine, O O O O
RIX4414 O O O O
oral O O O O
suspension, O O O O
when O O O O
co-administered O O O O
with O O O O
routine O O O O
childhood O O O O
vaccines O O O O
in O O O O
Chinese O O O O
infants.](/27149266/)Hum O O O O
Trial. O O O O
[Extraneous O O O O
agent O O O O
of O O O O
technical O O O O
Review. O O O O
Cited O O O O
by O O O O
- O O O O
[Detection O O O O
Porcine O O O O
Circovirus O O O O
1/2/3 O O O O
and O O O O
Genetic O O O O
Analysis O O O O
of O O O O
Porcine O O O O
Circovirus O O O O
2 O O O O
in O O O O
Wild O O O O
Boar O O O O
from O O O O
Jiangxi O O O O
Province O O O O
of O O O O
China.](/36009613/)Animals O O O O
(Basel). O O O O
2022 O O O O
Aug O O O O
and O O O O
porcine O O O O
circovirus-free O O O O
human O O O O
rotavirus O O O O
vaccine O O O O
in O O O O
healthy O O O O
infants: O O O O
a O O O O
phase O O O O
randomized O O O O
trial.](/32365189/)J O O O O
Infect O O O O
Dis. O O O O
2020 O O O O
May O O O O
4;225(12):2106-15. O O O O
doi: O O O O
10.1093/infdis/jiaa210. O O O O
Online O O O O
ahead O O O O
of O O O O
print. O O O O
J O O O O
Infect O O O O
Dis. O O O O
2020. O O O O
PMID: O O O O
32365189 O O O O
Free O O O O
PMC O O O O
article. O O O O
- O O O O
[Selected O O O O
Viruses O O O O
Detected O O O O
Clin O O O O
[Reservoirs Reason 3 O O
of Reason 3 O O
Porcine Reason 3 O O
Vet Reason 3 O O
Sci. Reason 3 O O
2019 Reason 3 O O
Sep Reason 3 O O
19;6:319. Reason 3 O O
10.3389/fvets.2019.00319. Reason 3 O O
eCollection Reason 3 O O
2019. Reason 3 O O
Front Reason 3 O O
Vet Reason 3 O O
Sci. Reason 3 O O
2019. Reason 3 O O
PMID: Reason 3 O O
31616677 Reason 3 O O
Free Reason 3 O O
PMC Reason 3 O O
article. Reason 3 O O
Review. Reason 3 O O
References Reason 3 O O
- Reason 3 O O
- Reason 3 O O
Tate Reason 3 O O
JE, Reason 3 O O
Patel Reason 3 O O
MM, Reason 3 O O
Steele Reason 3 O O
AD, Reason 3 O O
Gentsch Reason 3 O O
JR, Reason 3 O O
Payne Reason 3 O O
DC, Reason 3 O O
Cortese Reason 3 O O
MM, Reason 3 O O
Nakagomi Reason 3 O O
O, Reason 3 O O
Cunliffe Reason 3 O O
NA, Reason 3 O O
Jiang Reason 3 O O
B, Reason 3 O O
Neuzil Reason 3 O O
KM, Reason 3 O O
et Reason 3 O O
al.. Reason 3 O O
Global Reason 3 O O
impact Reason 3 O O
of Reason 3 O O
rotavirus Reason 3 O O
vaccines. Reason 3 O O
Expert Reason 3 O O
Rev Reason 3 O O
Vaccines Reason 3 O O
2010; Reason 3 O O
9:395-407; Reason 3 O O
PMID:20370550; Reason 3 O O
[http://dx.doi.org/10.1586/erv.10.17](http://dx.doi.org/10.1586/erv.10.17)- Reason 3 O O
[DOI](https://doi.org/10.1586/erv.10.17)- Reason 3 O O
[PubMed](/20370550/) Reason 3 O O
- Reason 3 O O
Tate Reason 3 O O
JE, Reason 3 O O
Patel Reason 3 O O
Steele Reason 3 O O
AD, Reason 3 O O
Gentsch Reason 3 O O
JR, Reason 3 O O
Payne Reason 3 O O
DC, Reason 3 O O
Cortese Reason 3 O O
MM, Reason 3 O O
Nakagomi Reason 3 O O
O, Reason 3 O O
Cunliffe Reason 3 O O
NA, Reason 3 O O
Jiang Reason 3 O O
B, Reason 3 O O
Neuzil Reason 3 O O
KM, Reason 3 O O
et Reason 3 O O
al.. Reason 3 O O
Global Reason 3 O O
impact Reason 3 O O
of Reason 3 O O
rotavirus Reason 3 O O
vaccines. Reason 3 O O
Expert Reason 3 O O
Rev Reason 3 O O
Vaccines Reason 3 O O
Glass Reason 3 O O
RI. Reason 3 O O
Global Reason 3 O O
illness Reason 3 O O
and Reason 3 O O
deaths Reason 3 O O
caused Reason 3 O O
by Reason 3 O O
rotavirus Reason 3 O O
disease Reason 3 O O
in Reason 3 O O
RI. Reason 3 O O
Global Reason 3 O O
illness Reason 3 O O
and Reason 3 O O
deaths Reason 3 O O
caused Reason 3 O O
by Reason 3 O O
rotavirus Reason 3 O O
disease Reason 3 O O
in Reason 3 O O
children. Reason 3 O O
Emerg Reason 3 O O
Infect Reason 3 O O
Dis Reason 3 O O
2003; Reason 3 O O
9:565-72; Reason 3 O O
A, Reason 3 O O
Lanata Reason 3 O O
C, Reason 3 O O
Boschi-Pinto Reason 3 O O
C, Reason 3 O O
Shibuya Reason 3 O O
K, Reason 3 O O
Steele Reason 3 O O
D, Reason 3 O O
Birmingham Reason 3 O O
M, Reason 3 O O
Glass Reason 3 O O
RI. Reason 3 O O
Global Reason 3 O O
mortality Reason 3 O O
associated Reason 3 O O
with Reason 3 O O
rotavirus Reason 3 O O
disease Reason 3 O O
among Reason 3 O O
children Reason 3 O O
in Reason 3 O O
2004. Reason 3 O O
J Reason 3 O O
Infect Reason 3 O O
Dis Reason 3 O O
C, Reason 3 O O
Shibuya Reason 3 O O
K, Reason 3 O O
Steele Reason 3 O O
D, Reason 3 O O
Birmingham Reason 3 O O
M, Reason 3 O O
Glass Reason 3 O O
RI. Reason 3 O O
Global Reason 3 O O
mortality Reason 3 O O
associated Reason 3 O O
with Reason 3 O O
rotavirus Reason 3 O O
disease Reason 3 O O
among Reason 3 O O
children Reason 3 O O
in Reason 3 O O
2004. Reason 3 O O
J Reason 3 O O
Infect Reason 3 O O
Dis Reason 3 O O
2009; Reason 3 O O
200 Reason 3 O O
Suppl Reason 3 O O
1:S9-S15; Reason 3 O O
PMID:19817620; Reason 3 O O
- Reason 3 O O
- Reason 3 O O
WHO Reason 3 O O
. Reason 3 O O
Meeting Reason 3 O O
of Reason 3 O O
the Reason 3 O O
immunization Reason 3 O O
Strategic Reason 3 O O
Advisory Reason 3 O O
Group Reason 3 O O
of Reason 3 O O
Experts, Reason 3 O O
April Reason 3 O O
2009-conclusions Reason 3 O O
and Reason 3 O O
recommendations. Reason 3 O O
Wkly Reason 3 O O
Epidemiol Reason 3 O O
Rec Reason 3 O O
2009; Reason 3 O O
84:220-36; Reason 3 O O
PMID:19499606 Reason 3 O O
- Reason 3 O O
[PubMed](/19499606/) Reason 3 O O
- Reason 3 O O
WHO Reason 3 O O
. Reason 3 O O
Meeting Reason 3 O O
of Reason 3 O O
the Reason 3 O O
immunization Reason 3 O O
Strategic Reason 3 O O
Advisory Reason 3 O O
Group Reason 3 O O
of Reason 3 O O
Experts, Reason 3 O O
April Reason 3 O O
2009-conclusions Reason 3 O O
and Reason 3 O O
recommendations. Reason 3 O O
Wkly Reason 3 O O
Epidemiol Reason 3 O O
Rec Reason 3 O O
2009; Reason 3 O O
B, Reason 3 O O
Espinoza Reason 3 O O
F, Reason 3 O O
Gillard Reason 3 O O
P, Reason 3 O O
Innis Reason 3 O O
BL, Reason 3 O O
et Reason 3 O O
al.. Reason 3 O O
Safety Reason 3 O O
and Reason 3 O O
efficacy Reason 3 O O
of Reason 3 O O
an Reason 3 O O
attenuated Reason 3 O O
vaccine Reason 3 O O
against Reason 3 O O
severe Reason 3 O O
rotavirus Reason 3 O O
B, Reason 3 O O
Espinoza Reason 3 O O
F, Reason 3 O O
Gillard Reason 3 O O
P, Reason 3 O O
Innis Reason 3 O O
BL, Reason 3 O O
et Reason 3 O O
al.. Reason 3 O O
Safety Reason 3 O O
and Reason 3 O O
efficacy Reason 3 O O
of Reason 3 O O
an Reason 3 O O
attenuated Reason 3 O O
vaccine Reason 3 O O
against Reason 3 O O
severe Reason 3 O O
rotavirus Reason 3 O O
gastroenteritis. Reason 3 O O
N Reason 3 O O
Engl Reason 3 O O
J Reason 3 O O
Med Reason 3 O O
2006; Reason 3 O O
354:11-22; Reason 3 O O
PMID:16394298; Reason 3 O O
Publication Reason 3 O O
types Reason 3 O O
MeSH Reason 3 O O
terms Reason 3 O O
Substances Reason 3 O O
Associated Reason 3 O O
data Reason 3 O O
LinkOut Reason 3 O O
- Reason 3 O O
more Reason 3 O O
resources Reason 3 O O
Full Reason 3 O O
Text Reason 3 O O
Sources Reason 3 O O
Other Reason 3 O O
Literature Reason 3 O O
Sources Reason 3 O O
Medical Reason 3 O O
Research Reason 3 O O
Materials Reason 3 O O
